Welcome to RareCyte Advance 
 Scientific posters and publications from RareCyte and its collaborators 

 


FEATURED POSTERS


Posters Presented by RareCyte at the AACR 2017 Annual Meeting


AACR 2017 Poster Simultaneous RNA Protein.pngSimultaneous visual assessment of RNA and protein expression in circulating tumor cells using the AccuCyte-CyteFinder System

Download this poster
 

 

 

AACR 2017 Poster ITOMIC.pngUsing Liquid Biopsies and NGS as Tools to Analyze Mutation Burden and Copy Number Variation in the Blood of a Patient with Triple Negative Breast Cancer to Better Inform Therapeutic Targets

Download this poster

 

AACR 2017 Poster extrapolating CTC counts.pngAccuracy of extrapolation of circulating tumor cell count from small blood volumes: statistical estimation using the AccuCyte® – CyteFinder® system 

Download this poster

 

AACR 2017 Poster MALDI-TOF.pngDetection of mutations in single circulating tumor cells using MALDI-TOF mass spectrometry 

Download this poster

 

 

 

AACR 2017 Poster Hodgkin Lymphoma.pngA multi-parameter assay for the detection of rare malignant cells in classic Hodgkin lymphoma  

Download this poster

 

 

 

AACR 2017 Poster VanDeven Case Study.pngA Novel Platform For The Identification And Characterization Of Rare MCPyV-Specific CD4 T cells

Download this poster

 

 

 

 

 

 

Covance poster thumbnail.png

Using Liquid Biopsies and NGS as Tools to Analyze Mutation Burden and Copy Number Variation in the Blood of a Patient with Triple Negative Breast Cancer to Better Inform Therapeutic Targets

Download this poster

 

 

 


FEATURED PUBLICATION


 

pre-natal_pub_graphic.pngEvidence for feasibility of fetal trophoblastic cell-based noninvasive prenatal testing  


Breman, A. M., Chow, J. C., U'Ren, L., Normand, E. A., Qdaisat, S., Zhao, L., Henke, D. M., Chen, R., Shaw, C. A., Jackson, L., Yang, Y., Vossaert, L., Needham, R. H. V., Chang, E. J., Campton, D., Werbin, J. L., Seubert, R. C.,Van den Veyver, I. B., Stilwell, J. L., Kaldjian, E. P., and Beaudet, A. L. (2016
 

Prenat Diagn, doi: 10.1002/pd.4924.

 

 



PUBLICATION ARCHIVES 

 

pre-natal_pub_graphic.png

Evidence for feasibility of fetal trophoblastic cell-based noninvasive prenatal testing..  


 Breman, A. M., Chow, J. C., U'Ren, L., Normand, E. A., Qdaisat, S., Zhao, L., Henke, D. M., Chen, R., Shaw, C. A., Jackson, L., Yang, Y., Vossaert, L., Needham, R. H. V., Chang, E. J., Campton, D., Werbin, J. L., Seubert, R. C.,Van den Veyver, I. B., Stilwell, J. L., Kaldjian, E. P., and Beaudet, A. L. (2016

Prenat Diagn, doi: 10.1002/pd.4924.

 


 

BMC_cell_graphic.pngHigh-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining. 


Daniel E Campton,Arturo B Ramirez,Joshua J Nordberg,Nick Drovetto,Alisa C Clein,Paulina VarshaskayaBarry H FriemelSteve QuarreAmy BremanMichael Dorschner, Sibel BlauC Anthony Blau, Daniel E SabathJackie L Stilwell and Eric P Kaldjian

BMC Cancer 2015 15:360

 

 

 



POSTER ARCHIVES 

 NIPT_Image.pngCell based non-invasive prenatal testing using NGS-based copy number assessment of fetal cells 

Presented  at ASHG 2016

 

 

 

 

TNBC_AACR_2016.pngGenomic Aberrations in CTCs and ctDNA in Triple-Negative  Breast Cancer

Presented at AACR, 2016

 

  

WGA_Methods_AACR_2016.pngComparison of whole genome amplification methods on single and pooled cells for comparative genomic hybridization array analysis 

Presented at AACR, 2016

 

 

  

CTC_Cluster_Poster_AACR_2016.pngCTCs and Clusters in Breast Cancer PDX Models 

Presented at AACR, 2016

 

 

 

 

 

  

Multi-level_prostate_cancer_AACR_2016.pngMulti-level analysis of prostate cancer circulating tumor cells allowing IHC-based identification,
6-parameter fluorescence phenotyping, and individual cell molecular analysis

Presented at AACR, 2016

 

 

   

Multi-level_analysis_of_prostate_cancer__2015.pngMulti-level analysis of circulating tumor cells in advanced prostate cancer using AccuCyte ® – CyteFinder ®

Presented at the Prostate Cancer Foundation
Scientific Retreat  2015

 

 

  

Multi-Omic_analysis__AACR_2015.pngMulti-level Comprehensive Multi-Omic Analysis of Circulating Tumor Cells Isolated from a Metastatic Triple-Negative Breast Cancer Patient to Identify Pathogenic Genomic Aberrations 

Presented at AACR  2015

 

  

Clinical_Performance_AACR_2015.pngClinical performance of the AccuCyte®–CyteFinder® System, a dual-technology platform for comprehensive collection and high resolution imaging of circulating tumor cells 

Presented at AACR  2015

 

 

Analysis_and_single-cell_retrieval__San_Antonio_2014.pngAnalysis and single-cell retrieval of circulating tumor cells to monitor treatment response and assess genotype in triple-negative breast cancer

Presented at the San Antonio 
Breast Cancer Symposium  2014

 

 

High_Recovery_multiplex_Analysis__AACR_2014.pngHigh-recovery multiplex analysis of circulating tumor cells by density-based enrichment, automated platform immunofluorescence staining, and digital microscopy 

Presented at AACR  2014

 


 

 Click to Subscribe to the Blog

 

 

ABOUT THE RARECYTE PLATFORM

rarecyte_logo_image.jpg

 RareCyte’s novel platform is an integrated set of technologies that seamlessly leverages existing laboratory workflows. AccuCyte collection technology stratifies blood components, comprehensively isolates nucleated cells, and transfers them to microscope slides. CyteFinder scanning and image analysis enables rapid and accurate characterization of individual cells from the enriched samples. Single cells of interest can then be retrieved and collected by CyteFinder’s integrated CytePicker module for genomic analysis using microarrays or next-generation sequencing.

 

Subscribe to receive new updates

Subscribe to RareCyte Advance  and we will send you announcements of new Posters and Publications as soon as they become available.

You can unsubscribe at any time.  

 

 

RareCyte Video 

This active video blog highlights applications of single cell analysis using the RareCyte platform.